UHLEN MATHIAS has a total of 11 patent applications. Its first patent ever was published in 1989. It filed its patents most often in United States, Australia and EPO (European Patent Office). Its main competitors in its focus markets measurement, biotechnology and pharmaceuticals are SANGUI BIO PTY LTD, BESST TEST APS and FUJIREBIO AMERICA INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 8 | |
#2 | Australia | 1 | |
#3 | EPO (European Patent Office) | 1 | |
#4 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Measurement | |
#2 | Biotechnology | |
#3 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Analysing materials | |
#2 | Therapeutic chemical compounds | |
#3 | Microbiology | |
#4 | Microorganisms | |
#5 | Peptides | |
#6 | Measuring microorganism processes |
# | Name | Total Patents |
---|---|---|
#1 | Uhlen Mathias | 10 |
#2 | Ponten Fredrik | 7 |
#3 | Moks Tomas | 3 |
#4 | Jirstrom Karin | 2 |
#5 | Brennan Donal J | 2 |
#6 | Jirström Karin | 1 |
#7 | Schwenk Jochen | 1 |
#8 | Jirstroem Karin | 1 |
#9 | Uhlin Mathias | 1 |
Publication | Filing date | Title |
---|---|---|
US2012269764A1 | RBM3 as a marker for malignant melanoma prognosis | |
AU3833889A | Apparatus and method for automated purification of extra-chromosomal dna from a cell suspension using a reaction device | |
EP0432162A1 | Apparatus and method for automated separation of extra-chromosomal dna from a cell suspension |